271 related articles for article (PubMed ID: 19194754)
1. A contemporary, population-based study of lymphedema risk factors in older women with breast cancer.
Yen TW; Fan X; Sparapani R; Laud PW; Walker AP; Nattinger AB
Ann Surg Oncol; 2009 Apr; 16(4):979-88. PubMed ID: 19194754
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and Consequences of Axillary Lymph Node Dissection in the Era of Sentinel Lymph Node Biopsy for Breast Cancer.
Yen TWF; Laud PW; Pezzin LE; McGinley EL; Wozniak E; Sparapani R; Nattinger AB
Med Care; 2018 Jan; 56(1):78-84. PubMed ID: 29087982
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements.
McLaughlin SA; Wright MJ; Morris KT; Giron GL; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ
J Clin Oncol; 2008 Nov; 26(32):5213-9. PubMed ID: 18838709
[TBL] [Abstract][Full Text] [Related]
4. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy.
Armer J; Fu MR; Wainstock JM; Zagar E; Jacobs LK
Lymphology; 2004 Jun; 37(2):73-91. PubMed ID: 15328760
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors.
McLaughlin SA; Wright MJ; Morris KT; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ
J Clin Oncol; 2008 Nov; 26(32):5220-6. PubMed ID: 18838708
[TBL] [Abstract][Full Text] [Related]
6. Surgeon specialization and use of sentinel lymph node biopsy for breast cancer.
Yen TW; Laud PW; Sparapani RA; Nattinger AB
JAMA Surg; 2014 Feb; 149(2):185-92. PubMed ID: 24369337
[TBL] [Abstract][Full Text] [Related]
7. Using the axillary reverse mapping technique to screen breast cancer patients with a high risk of lymphedema.
Liu S; Wang N; Gao P; Liu P; Yang H; Xie F; Wang S; Liu M; Wang S
World J Surg Oncol; 2020 Jun; 18(1):118. PubMed ID: 32482174
[TBL] [Abstract][Full Text] [Related]
8. Arm lymphoedema after axillary surgery in women with invasive breast cancer.
Sackey H; Magnuson A; Sandelin K; Liljegren G; Bergkvist L; Fülep Z; Celebioglu F; Frisell J
Br J Surg; 2014 Mar; 101(4):390-7. PubMed ID: 24536010
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node biopsy lowers the rate of lymphedema when compared with standard axillary lymph node dissection.
Golshan M; Martin WJ; Dowlatshahi K
Am Surg; 2003 Mar; 69(3):209-11; discussion 212. PubMed ID: 12678476
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer related lymphedema in patients with different loco-regional treatments.
Ozcinar B; Guler SA; Kocaman N; Ozkan M; Gulluoglu BM; Ozmen V
Breast; 2012 Jun; 21(3):361-5. PubMed ID: 22460058
[TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph node biopsy at the time of mastectomy does not increase the risk of lymphedema: implications for prophylactic surgery.
Miller CL; Specht MC; Skolny MN; Jammallo LS; Horick N; O'Toole J; Coopey SB; Hughes K; Gadd M; Smith BL; Taghian AG
Breast Cancer Res Treat; 2012 Oct; 135(3):781-9. PubMed ID: 22941538
[TBL] [Abstract][Full Text] [Related]
12. Racial disparities in adoption of axillary sentinel lymph node biopsy and lymphedema risk in women with breast cancer.
Black DM; Jiang J; Kuerer HM; Buchholz TA; Smith BD
JAMA Surg; 2014 Aug; 149(8):788-96. PubMed ID: 25073831
[TBL] [Abstract][Full Text] [Related]
13. The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer.
Rebegea L; Firescu D; Dumitru M; Anghel R
Chirurgia (Bucur); 2015; 110(1):33-7. PubMed ID: 25800313
[TBL] [Abstract][Full Text] [Related]
14. Quantifying the Impact of Axillary Surgery and Nodal Irradiation on Breast Cancer-Related Lymphedema and Local Tumor Control: Long-Term Results From a Prospective Screening Trial.
Naoum GE; Roberts S; Brunelle CL; Shui AM; Salama L; Daniell K; Gillespie T; Bucci L; Smith BL; Ho AY; Taghian AG
J Clin Oncol; 2020 Oct; 38(29):3430-3438. PubMed ID: 32730184
[TBL] [Abstract][Full Text] [Related]
15. Comparison of lymphedema in patients with axillary lymph node dissections to those with sentinel lymph node biopsy followed by immediate and delayed ALND.
Kuwajerwala NK; Feczko C; Dekhne N; Pettinga J; Lucia VC; Riutta J; Vicini F
Am J Clin Oncol; 2013 Feb; 36(1):20-3. PubMed ID: 22157215
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for lymphedema after breast cancer treatment.
Norman SA; Localio AR; Kallan MJ; Weber AL; Torpey HA; Potashnik SL; Miller LT; Fox KR; DeMichele A; Solin LJ
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2734-46. PubMed ID: 20978176
[TBL] [Abstract][Full Text] [Related]
17. Minimize the extent and morbidity of axillary dissection for node-positive breast cancer patients: implementation of axillary lymph node dissection based on breast lymphatics level.
Yuan Q; Hou J; He Y; Liao Y; Zheng L; Wu G
BMC Cancer; 2021 Mar; 21(1):293. PubMed ID: 33740930
[TBL] [Abstract][Full Text] [Related]
18. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.
Helyer LK; Varnic M; Le LW; Leong W; McCready D
Breast J; 2010; 16(1):48-54. PubMed ID: 19889169
[TBL] [Abstract][Full Text] [Related]
19. Sentinel node biopsy and quality of life measures in a Chinese population.
Chen JJ; Huang XY; Liu ZB; Chen TW; Cheng JY; Yang WT; Xu WP; Shao ZM; Shen ZZ; Wu J
Eur J Surg Oncol; 2009 Sep; 35(9):921-7. PubMed ID: 19233602
[TBL] [Abstract][Full Text] [Related]
20. Prospective study of shoulder strength, shoulder range of motion, and lymphedema in breast cancer patients from pre-surgery to 5 years after ALND or SLNB.
Belmonte R; Messaggi-Sartor M; Ferrer M; Pont A; Escalada F
Support Care Cancer; 2018 Sep; 26(9):3277-3287. PubMed ID: 29651594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]